THERAVANCE BIOPHARMA INC

Ticker: TBPH CUSIP: G8807B106 Class: Common Stock

EAM Investors, LLC's Holding History (CIK: 0001510989)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025

Shares 66,296 Value ($000) $1,240 Avg Close $16.59 Range $13.50 - $20.33

Q3 2025

Shares 66,258 Value ($000) $967 Avg Close $12.64 Range $10.82 - $14.87

Q3 2016

Shares 114,204 Value ($000) $4,139 Avg Close $27.84 Range $21.97 - $37.14

Q2 2016

Shares 33,758 Value ($000) $766 Avg Close $21.59 Range $15.00 - $24.76

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2025	66,296	$1,240	$16.59	$13.50 - $20.33
Q3 2025	66,258	$967	$12.64	$10.82 - $14.87
Q3 2016	114,204	$4,139	$27.84	$21.97 - $37.14
Q2 2016	33,758	$766	$21.59	$15.00 - $24.76